Evaluation Study: Obsessive-compulsive Disorders in Childhood and Young Adulthood
NCT04723485 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 625
Last updated 2025-05-13
Summary
Obsessive-compulsive disorders are very damaging illnesses that can already manifest in childhood and adolescence. With an average prevalence from 1 - 3%, they are one of the most frequently diagnosed psychiatric illness in these age groups. With the further use of data, the treatment success can be significantly improved; causal variables/predictors can be recognized, understood and taken carefully into account. The anticipated incremental knowledge will ultimately help children and young people with obsessive-compulsive disorders to receive faster and more effective treatment.
Conditions
- Obsessive-compulsive Disorder
Sponsors & Collaborators
-
Susanne Walitza
lead OTHER
Principal Investigators
-
Susanne Walitza, Prof. Dr. med. Dipl.-Psych. · Sponsor-Investigator
Eligibility
- Min Age
- 4 Years
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-05-01
- Primary Completion
- 2026-03-01
- Completion
- 2026-03-01
Countries
- Switzerland
Study Locations
More Related Trials
-
Developing Computerised CBT for Adults With OCD
NCT02398045 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Treatment of Obsessive-Compulsive Disorder (OCD) in Children
NCT00000384 ·Status: COMPLETED ·Phase: PHASE3
-
Attention Training for Childhood Obsessive Compulsive Disorder
NCT02114918 ·Status: COMPLETED ·Phase: NA
-
St. John's Wort Vs. Placebo in Obsessive-Compulsive Disorder.
NCT00035438 ·Status: COMPLETED ·Phase: PHASE2
-
Using Personalized Assessments in the Treatment of Childhood OCD
NCT06407648 ·Status: RECRUITING ·Phase: NA
-
EEG Evaluation of CBT for Obsessive-Compulsive Disorder
NCT07000812 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Computerized Training for Individuals Diagnosed With Obsessive-Compulsive and Related Disorders
NCT03182075 ·Status: COMPLETED ·Phase: NA
-
Overlapping Neural Circuits in Pediatric OCD
NCT02421315 ·Status: COMPLETED ·Phase: NA
-
Internet-delivered Attention Training for Obsessive-Compulsive Disorder
NCT02018848 ·Status: COMPLETED ·Phase: NA
-
Evaluating the Effects of a Computerized Training Program Coupled With Cognitive Behavioral Therapy (CBT) for OCD.
NCT03855943 ·Status: UNKNOWN ·Phase: NA
-
Efficacy of Agomelatine in Patients With Obsessive-Compulsive Disorder
NCT01108393 ·Status: COMPLETED ·Phase: PHASE2
-
Towards Personalized Medicine for OCD
NCT03852186 ·Status: COMPLETED ·Phase: NA
-
Waitlist-Control Trial of Smartphone CBT for Obsessive-Compulsive Disorder (OCD)
NCT03767491 ·Status: WITHDRAWN ·Phase: NA
-
Behavioral Treatment of Obsessive-Compulsive Symptoms in Youth With Prader-Willi Syndrome: A Pilot Project
NCT00742664 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Effect of a Family-Based CBT Self-Help Intervention for Adolescents With OCD
NCT06942494 ·Status: RECRUITING ·Phase: NA
-
Short Term Group Therapy for OCD
NCT00229320 ·Status: COMPLETED ·Phase: NA
-
An OCD Prevention Programme for at Risk Adults
NCT06262464 ·Status: RECRUITING ·Phase: NA
-
Assessing the Effects of a Neurobehavioral Intervention on Symptoms of Obsessive Compulsive Disorder
NCT01414023 ·Status: COMPLETED ·Phase: NA
-
Rituximab Treatment for Psychosis And/or Obsessive Compulsive Disorder with Probable Immune System Involvement
NCT04323566 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2
-
Efficacy of Psilocybin in OCD: a Double-Blind, Placebo-Controlled Study.
NCT03356483 ·Status: COMPLETED ·Phase: PHASE1
-
Open/Aftercare Treatment for Participants Diagnosed With Obsessive Compulsive Disorder
NCT03511534 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Quetiapine Augmentation in Severe Obsessive Compulsive Disorder
NCT00254735 ·Status: COMPLETED ·Phase: PHASE3
-
Internet Cognitive Behavior Therapy (CBT) for Obsessive Compulsive Disorder (OCD)
NCT01348529 ·Status: COMPLETED ·Phase: NA
-
Influence of Pregnenolone on Exposure Therapy in Obsessive-compulsive Disorder
NCT01949753 ·Status: UNKNOWN ·Phase: PHASE2
-
Efficacy and Safety Study of Low-Dose Ondansetron For Adjunctive Therapy In Adult Patients With Obsessive-Compulsive Disorder
NCT01275248 ·Status: TERMINATED ·Phase: PHASE2